Human Molecular Genetics Advance Access published online on November 5, 2007
Human Molecular Genetics, doi:10.1093/hmg/ddm322
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Genomic and functional profiling of human Down syndrome neural progenitors implicates S100B and Aquaporin 4 in cell injury
1 Department of Experimental Pharmacology, Faculty of Pharmacy, University Federico II of Naples Via Domenico Montesano 49, 80131 (Italy) 2 Center for Neurologic Diseases, Division of Neuropathology, Brigham and Women's Hospital, Harvard Medical School, Boston MA 02115 USA 3 Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02115 USA 4 Department of Pathology, Division of Neuropathology, Brigham and Women's Hospital, Harvard Medical School, Boston MA 02115 USA 5 Department of Neuropathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115 USA 6 Invitrogen, Carlsbad, CA 92008 USA 7 Department of Human Physiology and Pharmacology, "Vittorio Erspamer" Faculty of Pharmacy, University of Rome "La Sapienza"
* Correspondence to: Volney L. Sheen, M.D., Ph.D. Beth Israel Deaconess Medical Center, Department of Neurology, Harvard Medical School, Boston, MA 02115, Phone: (617) 667-2699, Fax: (617) 667-0800, E-mail: vsheen{at}bidmc.harvard.edu
Received August 8, 2007; Revised November 1, 2007; Accepted November 1, 2007
Down Syndrome (DS) is caused by trisomy of chr.21 and is characterized by mental retardation, seizures, and premature Alzheimer's disease. To examine neuropathological mechanisms giving rise to this disorder, we generated multiple human DS neural progenitor cell (NPC) lines from the 19-21 week frontal cortex and characterized their genomic and functional properties. Microarray profiling of DS progenitors indicated that increased levels of gene expression were not limited to chr.21, suggesting that increased expression of genes on chr.21 altered transcriptional regulation of a subset of genes throughout the entire genome. Moreover, many transcriptionally dysregulated genes were involved in cell death and oxidative stress. Network analyses suggested that upregulated expression of chr.21 genes such as S100B and amyloid precursor protein activated the stress response kinase pathways, and furthermore, could be linked to upregulation of the water channel aquaporin 4 (AQP4). We further demonstrate in DS NPCs that S100B is constitutively overexpressed, that overexpression leads to increased reactive oxygen species (ROS) formation and activation of stress response kinases, and that activation of this pathway results in compensatory AQP4 expression. In addition, AQP4 expression could be induced by direct exposure to ROS, and siRNA inhibition of AQP4 resulted in elevated levels of ROS following S100B?exposure. Finally, elevated levels of S100B-induced ROS and loss of AQP4 expression led to increased programmed cell death. These findings suggest that dysregulation of chr.21 genes in DS neural progenitors leads to increased ROS and thereby alters transcriptional regulation of cytoprotective, non-chr.21 genes in response to ongoing cellular insults.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  D. K. Slonim, K. Koide, K. L. Johnson, U. Tantravahi, J. M. Cowan, Z. Jarrah, and D. W. Bianchi Functional genomic analysis of amniotic fluid cell-free mRNA suggests that oxidative stress is significant in Down syndrome fetuses PNAS, June 9, 2009; 106(23): 9425 - 9429. [Abstract] [Full Text] [PDF]
|
|